Adcirca
/
Adcirca is a phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability. It is taken as an oral tablet and is available by prescription only. Patients are advised that Adcirca may cause a decrease in blood pressure and should not be used in combination with nitrates or in patients with severe hepatic impairment.
FAQs about Adcirca
What should I do if I miss a dose?
If you miss a dose of Adcirca, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Adcirca while pregnant or breastfeeding?
The use of Adcirca during pregnancy is not recommended, as it is not known whether it can harm an unborn baby. It is also not known if tadalafil passes into breast milk or could harm a nursing baby. Patients are advised to discuss potential risks with their healthcare provider, as noted in the Warnings and Precautions section of the label.
How should I store Adcirca?
Adcirca should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children. This storage information is outlined in the Storage section of the label.
Similar Drugs
25
commonly-prescribed
medication.